|
1
|
Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
|
JAMA
|
2003
|
11.39
|
|
2
|
Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
|
JAMA
|
2004
|
5.35
|
|
3
|
Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.
|
JAMA
|
2004
|
3.85
|
|
4
|
Cognitive function, gait speed decline, and comorbidities: the health, aging and body composition study.
|
J Gerontol A Biol Sci Med Sci
|
2007
|
3.61
|
|
5
|
Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial.
|
JAMA
|
2009
|
2.59
|
|
6
|
Effects of conjugated equine estrogen on stroke in the Women's Health Initiative.
|
Circulation
|
2006
|
2.40
|
|
7
|
Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 years.
|
JAMA Intern Med
|
2013
|
2.38
|
|
8
|
Effects of combination estrogen plus progestin hormone treatment on cognition and affect.
|
J Clin Endocrinol Metab
|
2006
|
2.03
|
|
9
|
Association between reported alcohol intake and cognition: results from the Women's Health Initiative Memory Study.
|
Am J Epidemiol
|
2005
|
1.83
|
|
10
|
Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life.
|
J Clin Oncol
|
2006
|
1.66
|
|
11
|
The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline.
|
Clin Trials
|
2004
|
1.52
|
|
12
|
UV light abuse as a substance-related disorder: clinical implications.
|
Arch Dermatol
|
2008
|
1.48
|
|
13
|
Managing the cognitive effects of brain tumor radiation therapy.
|
Curr Treat Options Oncol
|
2006
|
1.47
|
|
14
|
The rationale, design, and baseline characteristics of the Women's Health Initiative Memory Study of Younger Women (WHIMS-Y).
|
Brain Res
|
2013
|
1.44
|
|
15
|
Induction of withdrawal-like symptoms in a small randomized, controlled trial of opioid blockade in frequent tanners.
|
J Am Acad Dermatol
|
2006
|
1.40
|
|
16
|
Ultraviolet exposure is a reinforcing stimulus in frequent indoor tanners.
|
J Am Acad Dermatol
|
2004
|
1.35
|
|
17
|
Is neighborhood racial/ethnic composition associated with depressive symptoms? The multi-ethnic study of atherosclerosis.
|
Soc Sci Med
|
2010
|
1.29
|
|
18
|
Patients with psoriasis prefer solution and foam vehicles: a quantitative assessment of vehicle preference.
|
Cutis
|
2002
|
1.27
|
|
19
|
Inhibition of ileal bile acid transport and reduced atherosclerosis in apoE-/- mice by SC-435.
|
J Lipid Res
|
2003
|
1.21
|
|
20
|
The relationship between cognitive function and physical performance in older women: results from the women's health initiative memory study.
|
J Gerontol A Biol Sci Med Sci
|
2009
|
1.21
|
|
21
|
Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy.
|
J Clin Endocrinol Metab
|
2009
|
1.13
|
|
22
|
Designing clinical trials for assessing the effects of cognitive training and physical activity interventions on cognitive outcomes: the Seniors Health and Activity Research Program Pilot (SHARP-P) study, a randomized controlled trial.
|
BMC Geriatr
|
2011
|
1.10
|
|
23
|
Postmenopausal hormone therapy and cognitive outcomes: the Women's Health Initiative Memory Study (WHIMS).
|
J Steroid Biochem Mol Biol
|
2009
|
1.07
|
|
24
|
Symptom clusters in patients with newly-diagnosed brain tumors.
|
J Support Oncol
|
2007
|
1.02
|
|
25
|
Neuroanatomical target theory as a predictive model for radiation-induced cognitive decline.
|
Neurology
|
2013
|
1.02
|
|
26
|
Identifying mild cognitive impairment at baseline in the Ginkgo Evaluation of Memory (GEM) study.
|
Aging Ment Health
|
2009
|
1.02
|
|
27
|
Long-term effects of conjugated equine estrogen therapies on domain-specific cognitive function: results from the Women's Health Initiative study of cognitive aging extension.
|
J Am Geriatr Soc
|
2010
|
1.00
|
|
28
|
Do optimism and pessimism predict physical functioning?
|
J Behav Med
|
2002
|
0.99
|
|
29
|
Benchmarks for designing two-stage studies using modified mini-mental state examinations: experience from the Women's Health Initiative Memory Study.
|
Clin Trials
|
2006
|
0.99
|
|
30
|
Inhibition of the apical sodium-dependent bile acid transporter reduces LDL cholesterol and apoB by enhanced plasma clearance of LDL apoB.
|
Arterioscler Thromb Vasc Biol
|
2002
|
0.99
|
|
31
|
Correlates of health-related quality of life in women with severe facial blemishes.
|
Int J Dermatol
|
2006
|
0.98
|
|
32
|
Telephone interview for cognitive status (TICS) screening for clinical trials of physical activity and cognitive training: the seniors health and activity research program pilot (SHARP-P) study.
|
Int J Geriatr Psychiatry
|
2011
|
0.97
|
|
33
|
Association between alcohol intake and domain-specific cognitive function in older women.
|
Neuroepidemiology
|
2006
|
0.96
|
|
34
|
Patients with palmoplantar psoriasis have more physical disability and discomfort than patients with other forms of psoriasis: implications for clinical practice.
|
J Am Acad Dermatol
|
2003
|
0.94
|
|
35
|
Alzheimer's disease risk assessment using large-scale machine learning methods.
|
PLoS One
|
2013
|
0.91
|
|
36
|
Self report of skin problems among farmworkers in North Carolina.
|
Am J Ind Med
|
2008
|
0.89
|
|
37
|
Relative effects of tamoxifen, raloxifene, and conjugated equine estrogens on cognition.
|
J Womens Health (Larchmt)
|
2010
|
0.88
|
|
38
|
Differences in itch characteristics between psoriasis and atopic dermatitis patients: results of a web-based questionnaire.
|
Acta Derm Venereol
|
2011
|
0.86
|
|
39
|
Cognitive factors associated with adherence to oral antiestrogen therapy: results from the cognition in the study of tamoxifen and raloxifene (Co-STAR) study.
|
Cancer Prev Res (Phila)
|
2013
|
0.84
|
|
40
|
Piperazinyl glutamate pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation.
|
J Med Chem
|
2010
|
0.83
|
|
41
|
The association of dermatologist-diagnosed and self-reported skin diseases with skin-related quality of life in Latino migrant farmworkers.
|
Int J Dermatol
|
2008
|
0.81
|
|
42
|
Performance of a computer-based assessment of cognitive function measures in two cohorts of seniors.
|
Int J Geriatr Psychiatry
|
2013
|
0.81
|
|
43
|
The family impact of atopic dermatitis in children: the role of the parent caregiver.
|
Pediatr Dermatol
|
2003
|
0.81
|
|
44
|
Psychiatric disorders and cognitive dysfunction among older, postmenopausal women: results from the Women's Health Initiative Memory Study.
|
Am J Geriatr Psychiatry
|
2010
|
0.80
|
|
45
|
Corrective cosmetics are effective for women with facial pigmentary disorders.
|
Cutis
|
2005
|
0.80
|
|
46
|
Phase II study of Ginkgo biloba in irradiated brain tumor patients: effect on cognitive function, quality of life, and mood.
|
J Neurooncol
|
2012
|
0.79
|
|
47
|
Ascertaining dementia-related outcomes for deceased or proxy-dependent participants: an overview of the Women's Health Initiative Memory Study supplemental case ascertainment protocol.
|
Int J Geriatr Psychiatry
|
2011
|
0.78
|
|
48
|
Validity of Death Certificate and Hospital Discharge ICD Codes for Dementia Diagnosis: The Multi-Ethnic Study of Atherosclerosis.
|
Alzheimer Dis Assoc Disord
|
2016
|
0.77
|
|
49
|
Social sensitivity and acne: the role of personality in negative social consequences and quality of life.
|
Int J Psychiatry Med
|
2006
|
0.77
|
|
50
|
Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation.
|
Bioorg Med Chem Lett
|
2009
|
0.77
|
|
51
|
Part II: piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation.
|
Bioorg Med Chem Lett
|
2010
|
0.76
|
|
52
|
Piperazinyl-glutamate-pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation.
|
Bioorg Med Chem Lett
|
2009
|
0.76
|
|
53
|
Antidepressant Use and Subclinical Measures of Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis.
|
J Clin Psychopharmacol
|
2016
|
0.75
|
|
54
|
Measurement of health-related quality of life (HRQOL) associated with skin disease.
|
J Am Acad Dermatol
|
2004
|
0.75
|
|
55
|
Spanish dermatological vocabulary used by Mexican workers.
|
Dermatol Online J
|
2005
|
0.75
|
|
56
|
Women's cognitive health: postmenopausal dementia and the women's health initiative memory study.
|
Womens Health Issues
|
2004
|
0.75
|